首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2903篇
  免费   277篇
  国内免费   1篇
  2023年   16篇
  2022年   26篇
  2021年   42篇
  2020年   40篇
  2019年   48篇
  2018年   49篇
  2017年   48篇
  2016年   67篇
  2015年   142篇
  2014年   146篇
  2013年   171篇
  2012年   253篇
  2011年   237篇
  2010年   143篇
  2009年   135篇
  2008年   198篇
  2007年   177篇
  2006年   167篇
  2005年   171篇
  2004年   168篇
  2003年   153篇
  2002年   150篇
  2001年   43篇
  2000年   24篇
  1999年   32篇
  1998年   35篇
  1997年   20篇
  1996年   19篇
  1995年   28篇
  1994年   13篇
  1993年   20篇
  1992年   21篇
  1991年   18篇
  1990年   24篇
  1989年   10篇
  1988年   10篇
  1987年   8篇
  1986年   10篇
  1985年   5篇
  1984年   6篇
  1983年   5篇
  1982年   8篇
  1981年   8篇
  1979年   8篇
  1978年   6篇
  1976年   4篇
  1975年   4篇
  1974年   6篇
  1973年   4篇
  1969年   5篇
排序方式: 共有3181条查询结果,搜索用时 265 毫秒
971.
The Gram-positive anaerobic bacterium Propionibacterium acnes is a prevalent member of the normal skin microbiota of human adults. In addition to its suspected role in acne vulgaris it is involved in a variety of opportunistic infections. Multi-locus sequence-typing (MLST) schemes identified distinct phylotypes associated with health and disease. Being based on 8 to 9 house-keeping genes these MLST schemes have a high discriminatory power, but their application is time- and cost-intensive. Here we describe a single-locus sequence typing (SLST) scheme for P. acnes. The target locus was identified with a genome mining approach that took advantage of the availability of representative genome sequences of all known phylotypes of P. acnes. We applied this SLST on a collection of 188 P. acnes strains and demonstrated a resolution comparable to that of existing MLST schemes. Phylogenetic analysis applied to the SLST locus resulted in clustering patterns identical to a reference tree based on core genome sequences. We further demonstrate that SLST can be applied to detect multiple phylotypes in complex microbial communities by a metagenomic pyrosequencing approach. The described SLST strategy may be applied to any bacterial species with a basically clonal population structure to achieve easy typing and mapping of multiple phylotypes in complex microbiotas. The P. acnes SLST database can be found at http://medbac.dk/slst/pacnes.  相似文献   
972.
973.
974.
Enzyme extracts of the wild type yeast Zygosaccharomyces bisporus were applied for the pyruvate decarboxylase catalysed condensation of pyruvate and (R)-(+)-and (S)-(?)-perillyl aldehyde, (±)-citronellal, neral, geranial or (R)-(?)-myrtenal to form novel α-hydroxy ketones. Best yields were obtained when the transformation medium contained 25% (v/v) of the cosolvent N,N-dimethylformamide. Conversion of (R)-(+)-perillyl aldehyde to (1R)-1-hydroxy-1-[(4’R)-4’-isopropenyl-1-cyclohexen-1-yl]-2-propanone proceeded highly stereospecifically (>99% de), whereas the stereoselectivity was somewhat less in the transformation of (S)-(?)-perillyl aldehyde (58% de) and (R)-(?)-myrtenal (92% de). All of the new compounds imparted characteristic odour impressions as determined by means of GC-olfactometry.  相似文献   
975.

Background

In up to 30% of patients with ischemic stroke no definite etiology can be established. A significant proportion of cryptogenic stroke cases may be due to non-stenosing atherosclerotic plaques or low grade carotid artery stenosis not fulfilling common criteria for atherothrombotic stroke. The aim of the CAPIAS study is to determine the frequency, characteristics, clinical and radiological long-term consequences of ipsilateral complicated American Heart Association lesion type VI (AHA-LT VI) carotid artery plaques in patients with cryptogenic stroke.

Methods/Design

300 patients (age >49 years) with unilateral DWI-positive lesions in the anterior circulation and non- or moderately stenosing (<70% NASCET) internal carotid artery plaques will be enrolled in the prospective multicenter study CAPIAS. Carotid plaque characteristics will be determined by high-resolution black-blood carotid MRI at baseline and 12 month follow up. Primary outcome is the prevalence of complicated AHA-LT VI plaques in cryptogenic stroke patients ipsilateral to the ischemic stroke compared to the contralateral side and to patients with defined stroke etiology. Secondary outcomes include the association of AHA-LT VI plaques with the recurrence rates of ischemic events up to 36 months, rates of new ischemic lesions on cerebral MRI (including clinically silent lesions) after 12 months and the influence of specific AHA-LT VI plaque features on the progression of atherosclerotic disease burden, on specific infarct patterns, biomarkers and aortic arch plaques.

Discussion

CAPIAS will provide important insights into the role of non-stenosing carotid artery plaques in cryptogenic stroke. The results might have implications for our understanding of stroke mechanism, offer new diagnostic options and provide the basis for the planning of targeted interventional studies.

Trial Registration

NCT01284933
  相似文献   
976.
Island disharmony refers to the biased representation of higher taxa on islands compared to their mainland source regions and represents a central concept in island biology. Here, we develop a generalizable framework for approximating these source regions and conduct the first global assessment of island disharmony and its underlying drivers. We compiled vascular plant species lists for 178 oceanic islands and 735 mainland regions. Using mainland data only, we modelled species turnover as a function of environmental and geographic distance and predicted the proportion of shared species between each island and mainland region. We then quantified the over‐ or under‐representation of families on individual islands (representational disharmony) by contrasting the observed number of species against a null model of random colonization from the mainland source pool, and analysed the effects of six family‐level functional traits on the resulting measure. Furthermore, we aggregated the values of representational disharmony per island to characterize overall taxonomic bias of a given flora (compositional disharmony), and analysed this second measure as a function of four island biogeographical variables. Our results indicate considerable variation in representational disharmony both within and among plant families. Examples of generally over‐represented families include Urticaceae, Convolvulaceae and almost all pteridophyte families. Other families such as Asteraceae and Orchidaceae were generally under‐represented, with local peaks of over‐representation in known radiation hotspots. Abiotic pollination and a lack of dispersal specialization were most strongly associated with an insular over‐representation of families, whereas other family‐level traits showed minor effects. With respect to compositional disharmony, large, high‐elevation islands tended to have the most disharmonic floras. Our results provide important insights into the taxon‐ and island‐specific drivers of disharmony. The proposed framework allows overcoming the limitations of previous approaches and provides a quantitative basis for incorporating functional and phylogenetic approaches into future studies of island disharmony.  相似文献   
977.
Journal of Mammalian Evolution - Taeniolabis taoensis is an iconic multituberculate mammal of early Paleocene (Puercan 3) age from the Western Interior of North America. Here we report the...  相似文献   
978.
Ecosystems - Agroforestry can contribute to an increase in tree cover in historically forested tropical landscapes with associated gains in biodiversity and ecosystem functioning, but only if...  相似文献   
979.
Epidermal growth factor receptors (ErbB1-4) are oncogenic receptor tyrosine kinases (RTKs) that regulate diverse cellular processes. In this study, we combine measurement and mathematical modeling to quantify phospho-turnover at ErbB receptors in human cells and to determine the consequences for signaling and drug binding. We find that phosphotyrosine residues on ErbB1 have half-lives of a few seconds and therefore turn over 100-1000 times in the course of a typical immediate-early response to ligand. Rapid phospho-turnover is also observed for EGF-activated ErbB2 and ErbB3, unrelated RTKs, and multiple intracellular adaptor proteins and signaling kinases. Thus, the complexes formed on the cytoplasmic tail of active receptors and the downstream signaling kinases they control are highly dynamic and antagonized by potent phosphatases. We develop a kinetic scheme for binding of anti-ErbB1 drugs to receptors and show that rapid phospho-turnover significantly impacts their mechanisms of action.  相似文献   
980.
Breithaupt H 《EMBO reports》2011,12(7):641-643
Research infrastructures are a crucial component of modern biological research, but the EU has not yet figured out how to fund and maintain them.The development of recombinant gene technology in the 1970s heralded a new era of application-oriented research for molecular biology, with a huge economic impact. During the decades that have followed, biological research and development have become a major enterprise, with an increasing demand for sophisticated technologies, databases, tissue banks and other tools that range from microscopes and DNA sequencers to bioinformatics services and mutant collections. Biology has followed in the footsteps of physics and astronomy, which share costly instrumentation such as particle accelerators, observatories and satellites. A key difference is that biological research infrastructures are often distributed across several sites and are less costly to establish. Nevertheless, they are expensive to operate and maintain, and need long-term financial support.There is no doubt among scientists that research infrastructures are essential for biomedicine and the life sciencesThe European Union (EU) regards biomedical research as an important component of its future economic and social development as part of its ''Innovation Union'' strategy (EC, 2010), but the necessary creation and operation of research infrastructures is not keeping pace. European biologists have been highlighting the problem for years (van Dyck, 2005), to the effect that some pan-European infrastructures for biomedical research and the life sciences have been created, such as the European Bioinformatics Institute (EBI; Hinxton, UK). The European Commission (EC) also established the European Strategy Forum on Research Infrastructures (ESFRI) in 2002, to define the infrastructures required for international research (ESFRI, 2006, 2011). However, most of the planned projects for the biomedical and life sciences (ESFRI, 2011)
ProjectConstruction costs (million €)Operation costs (million €)
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)1703
European Advanced Translational Research Infrastructure in Medicine (EATRIS)20–1003–8
European Clinical Research Infrastructures Network (ECRIN)03.5
European Life Science Infrastructure for Biological Information (ELIXIR)470100
European Marine Biology Resource Centre (EMBRC)10060
European Infrastructure of Open Screening Platforms for Chemical Biology (EU-OPENSCREEN)4040
European Biomedical Imaging Infrastructure (Euro-Bioimaging)600160
European Research Infrastructure on Highly Pathogenic Agents (ERINHA)17424
European Infrastructure for Phenotyping and Archiving of Model Mammalian Genomes (Infrafrontier)18080
An Integrated Structural Biology Infrastructure for Europe (INSTRUCT)30025
Infrastructure for Analysis and Experimentation on Ecosystems (ANAEE)21012
Infrastructure for Systems Biology-Europe (ISBE)300100
Microbial Resource Research Infrastructure (MIRRI)19010.5
Open in a separate windowAs part of the ongoing discussion about the EC''s next framework programme for research, a hearing took place on 5 May at the European Parliament (EP) in Brussels, Belgium, to discuss the long-term future of biomedical research infrastructures in Europe. A few members of the EP and their staff, and scientists and representatives from the EC, debated models of how to develop and support global research infrastructure projects. Predictably, the most important questions were about who would pay the bills. “We need conditions to provide stable funding and support, particularly in economically difficult times,” said Antonio Correia de Campos, MEP and vice chairman of the EP''s Science and Technology Options Assessment....well-funded research infrastructures with sophisticated equipment and experienced staff generate a huge return on investmentThere is no doubt among scientists that research infrastructures are essential for biomedicine and the life sciences. Janet Thornton, Director of the EBI, explained that centrally managed infrastructures have a crucial role at all levels, from basic to translational research to product development. Ivan Baines, Chief Operating Officer at the Max Planck Institutes in Dresden, Germany, and Miami, USA, stressed that infrastructures make research more efficient by giving scientists access to sophisticated services, tools and technology that no research institute or university would be able to afford alone. Globally shared research infrastructures are therefore more cost-efficient because they reduce redundancy and enable more-efficient use of data and tools—a clear ''economy of scale'' effect. In general, as Baines commented, well-funded research infrastructures with sophisticated equipment and experienced staff generate a huge return on investment.Not surprisingly, research infrastructures are set to play a central role in the EU''s Innovation Union. The overall rationale is to create a European research landscape clustered around shared research infrastructures in order to meet major challenges, such as tackling global climate change, the health issues of an ageing population, clean and sustainable energy and water production, sustainable food supplies and the risk of disease pandemics. Moreover, the infrastructures themselves would be linked to each other to share data and expertise so as to form a network of pan-European institutions and facilities that support scientists at every step of their research. The proposed Euro-Bioimaging project, for example, would include research institutes, universities and commercial partners that provide state-of-the-art imaging technology to the scientific community and promote standardization, best practice and coordination of research, in addition to researching and developing new imaging technologies.In their 2006 roadmap, the ESFRI recommended creating six biomedical research infrastructures—a number expanded to 10 in their 2008 roadmap (ESFRI, 2006). In addition, the roadmap proposes the creation of e-infrastructures to connect and support increasingly diverse and distributed sites. Just two days before the hearing, the ESFRI published its 2010 roadmap, which lists three more projects and strongly reiterates the important role for pan-European research infrastructures (ESFRI, 2011).What the 2010 roadmap does not say is who is going to pay. Initial funding from the EC runs out in 2011 and has been earmarked to support the preparatory phase, but not the creation of infrastructure projects, let alone their maintenance and operation. The main problem is that most EU member states alone cannot fund and support even a medium-sized research infrastructure. Unlike the US federal government, which, with the sheer size of its budget, can finance globally shared research institutes or facilities such as the NIH, NASA and the Public Library of Science, even the largest EU member states would be overwhelmed by such costly enterprises.Hervé Pero from the EC''s Directorate Generale for Research and Executive Secretary of the ESFRI identified the major problems for internationally shared research infrastructures: insufficient funding, complex management of diverse and distributed enterprises, insufficient policy tools including validation, legal issues and guaranteeing access for all scientists from the 27 EU member states. Moreover, some national governments are reluctant to finance globally used research institutions that do not directly provide tangible benefits to their economies. “Sometimes it is easy to convince a research minister because he''s a scientist; it''s not so easy to convince financial ministers,” Pero said.The EC therefore proposes to use funding models already used by CERN and the European Molecular Biology Laboratory, in which interested parties—states, philanthrophists, charities or funding organizations—commit to supporting research infrastructure such as databases, bioinformatics services, tissue banks or microscope facilities. “Member states are the key partners for this initiative,” de Campo said. The EC would organize and coordinate support, and create the legal and political framework. The ambitious aim, according to the ESFRI, is that by 2015 the most important research infrastructures should be up and running and freely accessible to the scientific community.It is not clear, however, whether and to what extent EU member states will fund pan-European infrastructures: the UK, Finland and Poland, among others, have earmarked some money for the establishment of ELIXIR—the infrastructure for biological information—and other projects, but this is far from what is needed and does not address the problem of long-term operation and maintenance, particularly in these difficult economic times. Moreover, coordinating support for the 13 projects recommended by the ESFRI remains a major challenge. “It is unprecedented to coordinate all these activities across 27 countries,” Baines remarked.“In times of global challenges, the best answer for the EU is to pull together and not go for nationalistic solutions”Mere coordination by the EC to organize support from individual member states might, therefore, not be enough. Bernd Pulverer, head of publications for EMBO, who moderated the hearing, enquired whether a European agency similar to the European Research Council (ERC), which funds basic research, would be a solution to the problem of guaranteeing long-term stability. Pero agreed that an agency that identifies needs and funds the establishment, maintenance and operation of pan-European infrastructures would be a viable solution, but he was not optimistic. “It would be the way forward to create a body at the EU level to coordinate funds and actions. Unfortunately, the time is not right,” he said. Given the economic crisis, various member states are not keen to contribute more money to the EU. Moreover, the ERC has not existed for long enough to convince the EP and ministers that additional funding for another agency for research would benefit the whole EU. Nevertheless, the EC is aware of the problem of long-term financial support, and has therefore included research infrastructures in its proposal for the next research framework.Some MEPs at the hearing share the concerns of scientists about the viability of long-term funding. Vittorio Prodi expressed concern over nationalistic reflexes that would be an impediment to international research. Instead, he said the EU should focus on the added value of pan-European research infrastructures and their potential for development. Even so, economic and other factors may well force the EU to take a more proactive role. “In times of global challenges, the best answer for the EU is to pull together and not go for nationalistic solutions,” Prodi said, “[and to] give the EU directly the resources that are needed.”  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号